Impairment in mTOR activity has been demonstrated in fibroblasts and podocytes of patients with FD, and this may in part be explained by accumulation of sphingolipids in lysosomes, disrupting mTOR’s activity [47]. The gene discussed is MTOR; the disease is Fabry disease.